Financials
- Market Capitalization 4.29 B
- Employee 137
- Founded 2017
- CEO N/A
- Website www.tangotx.com
- Headquarter Delaware, United States
- FIGI BBG00WFDDRS0
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-10.18
Fiyat/satışlar oranı
16.5
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1426 | VKTX Viking Therapeutics, Inc. - Common Stock | 37.97 USD | -0.39% | -9.29% | +30.30% | +19.59% | 4.41 B USD | ||
| 1436 | ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 25.49 USD | -0.04% | -2.52% | +20.81% | +16.18% | 4.36 B USD | ||
| 1450 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 39.73 USD | -3.73% | -7.54% | +12.10% | +160.87% | 4.27 B USD | ||
| 1529 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 33.29 USD | +0.03% | -9.19% | +6.77% | -8.22% | 3.89 B USD |